AR203895A1 - Procedimiento para preparar una composicion antibiotica seca de 7-(d-2-formiloxi-2-fenilacetamido)-3-(1-metil-1h-tetrazol-5-il-tiometil)-3-cefem- -carboxilato de sodio - Google Patents

Procedimiento para preparar una composicion antibiotica seca de 7-(d-2-formiloxi-2-fenilacetamido)-3-(1-metil-1h-tetrazol-5-il-tiometil)-3-cefem- -carboxilato de sodio

Info

Publication number
AR203895A1
AR203895A1 AR257697A AR25769775A AR203895A1 AR 203895 A1 AR203895 A1 AR 203895A1 AR 257697 A AR257697 A AR 257697A AR 25769775 A AR25769775 A AR 25769775A AR 203895 A1 AR203895 A1 AR 203895A1
Authority
AR
Argentina
Prior art keywords
cefem
formyloxy
phenylacetamide
thiomethyl
tetrazol
Prior art date
Application number
AR257697A
Other languages
English (en)
Spanish (es)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23765656&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR203895(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of AR203895A1 publication Critical patent/AR203895A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AR257697A 1974-02-22 1975-02-19 Procedimiento para preparar una composicion antibiotica seca de 7-(d-2-formiloxi-2-fenilacetamido)-3-(1-metil-1h-tetrazol-5-il-tiometil)-3-cefem- -carboxilato de sodio AR203895A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US444622A US3928592A (en) 1974-02-22 1974-02-22 Antibiotic pharmaceutical compositions

Publications (1)

Publication Number Publication Date
AR203895A1 true AR203895A1 (es) 1975-10-31

Family

ID=23765656

Family Applications (1)

Application Number Title Priority Date Filing Date
AR257697A AR203895A1 (es) 1974-02-22 1975-02-19 Procedimiento para preparar una composicion antibiotica seca de 7-(d-2-formiloxi-2-fenilacetamido)-3-(1-metil-1h-tetrazol-5-il-tiometil)-3-cefem- -carboxilato de sodio

Country Status (24)

Country Link
US (1) US3928592A (fi)
JP (1) JPS6119605B2 (fi)
AR (1) AR203895A1 (fi)
AT (1) AT356264B (fi)
BE (1) BE825653A (fi)
CA (1) CA1043261A (fi)
CH (1) CH620929A5 (fi)
CS (1) CS189689B2 (fi)
DD (1) DD117807A5 (fi)
DE (1) DE2506622C2 (fi)
DK (1) DK153919C (fi)
ES (1) ES434976A1 (fi)
FR (1) FR2261772B1 (fi)
GB (1) GB1493676A (fi)
HU (1) HU174129B (fi)
IE (1) IE40671B1 (fi)
IL (1) IL46650A (fi)
NL (1) NL179976C (fi)
PH (1) PH12058A (fi)
PL (1) PL109311B1 (fi)
SE (1) SE406153B (fi)
SU (1) SU659094A3 (fi)
YU (1) YU41875A (fi)
ZA (1) ZA75975B (fi)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4054738A (en) * 1975-12-22 1977-10-18 Eli Lilly And Company Sodium cefamandole crystalline forms
JPS5283956A (en) * 1976-01-01 1977-07-13 Lilly Co Eli Antibiotic method and medical composition
JPS5329936A (en) * 1976-08-31 1978-03-20 Takeda Chem Ind Ltd Antibiotic composition
JPS5711909A (en) * 1980-06-23 1982-01-21 Shionogi & Co Ltd Stable freeze-dried preparation of beta-lactam
CA2011365A1 (en) * 1989-03-06 1990-09-06 Eugene L. Inman Diluent formulation for daptomycin
JP4873207B2 (ja) * 2001-02-26 2012-02-08 東レ・ファインケミカル株式会社 光学活性カルボン酸クロリドの精製方法
CN100554271C (zh) * 2007-07-27 2009-10-28 苏州中联化学制药有限公司 抗菌素头孢孟多酯钠的合成方法
CN101880290B (zh) * 2010-06-28 2012-03-07 海南新中正制药有限公司 头孢孟多酯钠的制备方法
WO2013057196A1 (en) * 2011-10-20 2013-04-25 Dsm Sinochem Pharmaceuticals Netherlands B.V. Process for the preparation of cefamandole nafate
WO2013057197A1 (en) * 2011-10-20 2013-04-25 Dsm Sinochem Pharmaceuticals Netherlands B.V. Process for the formylation of cefamandole
US9834567B1 (en) * 2014-12-16 2017-12-05 Tianjin University Crystalline form of cefamandole nafate compound, preparation and preparing method thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1767891C3 (de) * 1968-06-28 1980-10-30 Pfizer Verfahren zur Herstellung von wäßrigen arzneilichen Lösungen für die parenterale, perorale und lokale Anwendung mit einem Gehalt an einem Tetracyclinderivat
US3641021A (en) * 1969-04-18 1972-02-08 Lilly Co Eli 3 7-(ring-substituted) cephalosporin compounds

Also Published As

Publication number Publication date
DK65575A (fi) 1975-10-20
ES434976A1 (es) 1976-12-16
SE406153B (sv) 1979-01-29
HU174129B (hu) 1979-11-28
DD117807A5 (fi) 1976-02-05
US3928592A (en) 1975-12-23
DE2506622C2 (de) 1987-02-26
NL179976C (nl) 1986-12-16
SU659094A3 (ru) 1979-04-25
CH620929A5 (fi) 1980-12-31
DE2506622A1 (de) 1975-08-28
NL179976B (nl) 1986-07-16
YU41875A (en) 1982-05-31
FR2261772A1 (fi) 1975-09-19
ZA75975B (en) 1976-09-29
AU7833975A (en) 1976-08-19
JPS50126817A (fi) 1975-10-06
PL109311B1 (en) 1980-05-31
NL7502045A (nl) 1975-08-26
IL46650A (en) 1977-10-31
CA1043261A (en) 1978-11-28
GB1493676A (en) 1977-11-30
IE40671B1 (en) 1979-07-18
ATA128475A (de) 1979-09-15
DK153919C (da) 1989-02-06
AT356264B (de) 1980-04-25
SE7501985L (fi) 1975-08-25
IE40671L (en) 1975-08-22
JPS6119605B2 (fi) 1986-05-17
PH12058A (en) 1978-10-18
IL46650A0 (en) 1975-05-22
FR2261772B1 (fi) 1980-01-04
BE825653A (fr) 1975-08-18
CS189689B2 (en) 1979-04-30
DK153919B (da) 1988-09-26

Similar Documents

Publication Publication Date Title
AR205578A1 (es) Procedimiento para preparar compuesto de 3-fenoxi-3-fenilpropilamina
AR209242A1 (es) Un procedimiento para preparar una composicion antibiotica estable
AR217844A1 (es) Procedimiento para preparar una composicion antibiotica estable
FI53718C (fi) Foerfarande foer framstaellning av antibiotikumet tienamycin
AR206937A1 (es) Procedimiento para preparar compuestos de 1-sustituido-4-alquil-4-fenil-piperidina
AR231986A1 (es) Procedimiento para preparar antibioticos de cefalosporina
AR203895A1 (es) Procedimiento para preparar una composicion antibiotica seca de 7-(d-2-formiloxi-2-fenilacetamido)-3-(1-metil-1h-tetrazol-5-il-tiometil)-3-cefem- -carboxilato de sodio
AR206315A1 (es) Procedimiento para la preparacion de compuestos de cefalosporina
AR207582A1 (es) Procedimiento para preparar derivados de diaminociclitole
SE7602565L (sv) Forfarande for framstellning av en ny kristallin form av ett cefalosporinsalt
SE429235B (sv) Forfarande for framstellning av antibiotika av cefalosporintyp.
SE426830B (sv) Forfarande for framstellning av cefalosporinforeningar
MX3514E (es) Procedimiento para la preparacion de derivados de 1,3 tiazolidinas
NO138845C (no) Fremgangsmaate for fremstilling av natriumperkarbonat
AR206234A1 (es) Procedimiento para preparar 2-mercaptobenzotiazol
SE423236B (sv) Forfarande for framstellning av natriumsalter av amoxicillin
NO145434C (no) 5-cykloheksyl-1-indanol for anvendelse som utgangsmateriale ved fremstilling av 5-cykloheksylindanforbindelser
AR208548A1 (es) Procedimiento para la preparacion de derivados de n-butilamina
AR205398A1 (es) Procedimiento para preparar derivados de cefalosporina
RO72884A (ro) Procedeu pentru prepararea de compusi indolici
SE430162B (sv) Nytt forfarande for framstellning av cefalosporinderivat
AR213082A1 (es) Procedimiento para preparar nuevos derivados de las 5-(2-morfolinitmetil)-dibenzazepinas
AR211234A1 (es) Procedimiento para preparar derivados de 7-acilamido cefalosporina
MX4853E (es) Procedimiento para preparar derivados de cefalosporina
MX6014E (es) Procedimiento para preparar derivados de cefalosporina